Patients with certain types of ovarian cancer now have access to three clinical trials that study the results of new therapies.
These therapies are advancing ovarian cancer research in new and exciting ways, says gynecologic oncologist Dr. Charles Anderson, who was instrumental in bringing the trials to Willamette Valley Cancer Institute and Research Center. Read more.
Approximately 20 percent of women will develop a pelvic mass at some point in their lives. When a woman is referred to Willamette Valley Cancer Institute, a gynecologic oncologist works to determine whether the mass is benign or malignant.
Understandably, this can be an anxious time for patients and having the right information is important. “When a patient has a consultation, we discuss different scenarios,” say gynecologic oncologist Dr. Kathleen Yang. “What if the mass is benign? And what if the mass is cancerous? We also describe the procedure the patient will undergo and the steps we will take.” Read more.
As a wife and mother to five children, Sandra Brace’s plate was already full. Her youngest child, Sawyer, arrived in May of 2015. At 35 years old and symptom-free, she never expected to have cancer.
“My husband and I thought we were done having babies, then I got pregnant with Sawyer,” Sandra said. “My doctor actually found the cancer at my six-week post-partum checkup.”
Sandra’s doctor performed two biopsies, and both indicated the growth on her cervix consisted of pre-cancerous cells. Her doctor felt strongly that it was cancer, even though Sandra admits she was in denial. Read more.
When you or a loved one is going through cancer, it's hard to know where to turn for support. For many reasons, it can be uncomfortable to talk with loved ones about what you're going through. Read more.
Historically, ovarian cancer has been referred to as a "silent killer" because it was thought there were no symptoms until the disease had spread throughout a woman's pelvis and abdomen. But studies have determined otherwise. Women can have symptoms of ovarian cancer that, if caught early, can greatly alter the long-term prognosis of the cancer. Read more.